Inflammation and Vascular Calcification

Blood Purification - Tập 23 Số 1 - Trang 64-71 - 2005
Sharon M. Moe1, Neal X. Chen2
1Indiana University and Roudebush Veterans Affairs Medical Center, Indianapolis, IN 46260, USA. [email protected]
2Nephrology

Tóm tắt

Both vascular calcification and inflammation are common in patients with chronic kidney disease (CKD). In patients on dialysis, there is increased coronary artery and peripheral artery calcification compared to the general population. Both intimal (atherosclerotic) and medial calcification in CKD patients are associated with increased morbidity and mortality. Vascular calcification is an active cell-mediated process, and likely reflects a transformation of vascular smooth muscle cells to osteoblast-like cells. Pooled uremic serum can induce this transformation, but the mechanism by which it does so is not yet clear. Several mediators of inflammation such as oxidation, carbonyl stress, C-reactive protein, and cytokines may directly stimulate vascular calcification. In addition, inflammation itself reduces fetuin-A, a naturally occurring inhibitor of vascular calcification which binds excess mineral in serum. The combination of the acceleration of vascular calcification together with impaired defense mechanisms creates a uremic milieu primed for extra-osseous calcification.

Từ khóa


Tài liệu tham khảo

10.1053%2Fajkd.1998.v32.pm9820470

10.1046%2Fj.1523-1755.2000.00173.x

10.1097%2F01.ASN.0000019641.41496.1E

10.1093%2Fndt%2F15.suppl_5.81

10.1046%2Fj.1523-1755.63.s85.25.x

10.1172%2FJCI200318921

10.1056%2FNEJMoa021993

10.1097%2F01.ASN.0000128966.55133.69

10.1046%2Fj.1523-1755.1999.00273.x

10.1016%2FS0272-6386%2800%2970200-9

10.1046%2Fj.1523-1755.61.s80.18.x

10.1046%2Fj.1523-1755.2002.00562.x

10.1016%2FS0140-6736%2802%2911473-5

10.1097%2F00007890-200003150-00034

10.1016%2FS0002-9343%2899%2900066-2

10.1053%2Fajkd.1998.v32.pm9669431

10.1046%2Fj.1523-1755.1999.00422.x

10.1046%2Fj.1523-1755.61.s80.19.x

10.1053%2Fajkd.2003.50094

10.1016%2FS0272-6386%2896%2990363-7

10.1053%2Fj.semnephrol.2003.08.014

10.1016%2FS0735-1097%2897%2900443-9

10.1016%2F0021-9150%2890%2990009-8

10.1053%2Fj.ajkd.2003.10.014

10.1056%2FNEJM200005183422003

10.1161%2F01.CIR.0000020222.63035.C0

10.1046%2Fj.1523-1755.2002.00434.x

10.1093%2Fndt%2Fgfg093

10.1093%2Fndt%2Fgfh303

10.1007%2Fs003920070097

10.1093%2Fndt%2F15.2.218

10.1161%2F01.HYP.0000117153.48029.d1

10.1002%2F%28SICI%291096-9896%28199805%29185%3A1%3C1%3A%3AAID-PATH89%3E3.0.CO%3B2-J

10.2337%2Fdiacare.17.11.1252

10.1089%2F154099904323087060

10.1046%2Fj.1525-139X.2003.16023.x

10.1038%2Fki.1990.19

10.1046%2Fj.1523-1755.2003.00932.x

10.1001%2Fjama.287.12.1548

10.1093%2Fndt%2F15.7.1014

10.1016%2F0002-9343%2879%2991118-5

10.1093%2Fndt%2Fgfg414

10.1007%2Fs00467-003-1276-0

10.1056%2FNEJM199901143400207

10.1046%2Fj.1523-1755.63.s84.21.x

10.1172%2FJCI116391

10.1007%2Fs003920070101

10.1053%2Fajkd.2001.24533

10.1046%2Fj.1523-1755.2002.00170.x

10.1016%2FS0092-8674%2800%2980257-3

10.1016%2FS0092-8674%2800%2980258-5

10.1093%2Fndt%2F17.suppl_8.33

10.1093%2Fndt%2Fgfh1054

10.1046%2Fj.1523-1755.2002.00625.x

10.1046%2Fj.1523-1755.2003.00820.x

10.1093%2Fndt%2F17.suppl_8.16

10.1016%2FS0140-6736%2801%2907217-8

10.1097%2F01.ASN.0000093240.84097.FE

10.1016%2FS0891-5849%2801%2900610-4

10.1097%2F00041433-199710000-00010

10.1111%2Fj.1523-1755.2004.00736.x

10.1172%2FJCI119285

10.1006%2Fbbrc.1999.0625

10.1093%2Fndt%2Fgfg200

10.1161%2Fhy1001.096211

10.1093%2Fndt%2Fgfh1059

10.1046%2Fj.1523-1755.1998.00981.x

10.1161%2Fhc0502.102969

10.1161%2F01.CIR.0000053730.47739.3C

10.1053%2Fajkd.2003.50005

10.1074%2Fjbc.M210868200

10.1172%2FJCI200317202

10.1016%2FS0140-6736%2803%2912710-9